People with Crohn's disease can now start Skyrizi at home
Published
The FDA approved a way to begin Skyrizi treatment with a wearable on-body injector at weeks 0, 2, 4 and 8, instead of only through IV infusions at a clinic. The IV option is still available, and maintenance doses continue every eight weeks. Talk with your gastroenterologist and insurer about which starting route is covered for you.
Source: AbbVie
This is a plain-language summary. Read the original source for full details.